Dr. Shagufta Shaheen, MD

Dr. Shaheen practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Shaheen's NPI, 1659529089, was assigned on August 27, 2008. Dr. Shaheen graduated from M.G.M. Medical College in 2003. Dr. Shaheen holds California license A128552.

Dr. Shaheen's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Shaheen's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Shaheen is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Shaheen to 2 more hospitals and 1 medical group, each named with a free account. Dr. Shaheen's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shaheen practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Shaheen's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Shaheen is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Shaheen's licenses on file in 3 states: California, Massachusetts and Illinois.

Dmand AI lists anemia, congestive heart failure, diabetic emergency, fibromyalgia and chronic pain, mini-stroke (TIA), pulmonary embolism, rash and sepsis among the conditions Dr. Shaheen treats.

CMS data shows 730 Medicare services from Dr. Shaheen across 7 procedure codes in 2024, for 211 Medicare patients. Medicare paid $87,082 for them.

CMS counts 211 Medicare patients who saw Dr. Shaheen in 2024. The largest group is 65 to 74, with 107 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shaheen's median patient age at 63, with 50% women.

In 2024, Dr. Shaheen wrote 73 Medicare Part D claims for 33 patients. 78% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $108 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shaheen for performance year 2024, reported as part of a group. Dr. Shaheen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shaheen as offering telehealth.

Dmand AI links 22 papers to Dr. Shaheen, published from 2013 to 2025. 2013 was the busiest year, with 6. The most frequent topics are Neuroendocrine Tumors, Octreotide and Positron-Emission Tomography. Dr. Shaheen has published most often in Case Rep Oncol. Dr. Shaheen's most frequent co-authors are Achuta Kumar Guddati, MD, George A. Fisher, MD and Thorvardur R. Halfdanarson, MD.

Dmand AI links Dr. Shaheen to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoid Tumor, Non functioning pancreatic endocrine tumor and Somatostatinoma.

CMS Open Payments shows 62 general payments to Dr. Shaheen from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Exelixis Inc. paid the most, $10,711.

Dr. Shaheen graduated from M.G.M. Medical College in 2003. Dr. Shaheen is a member of ASCO.

Dr. Shaheen is in network with 10 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.